Test Price
2,800 AED✅ Home Collection Available
FGFR2 Gene Saethre-Chotzen Syndrome Genetic Test in UAE | AED 2800 | DHA Compliant
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity – ISO 9001:2015 certified NGS processing ensures unmatched accuracy.
- VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily from 8 AM to 11 PM.
- Post-Test Clinical Guidance – Telephonic result interpretation by DHA-licensed genetic counsellor.
- Insurance Support – Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This next-generation sequencing test screens the entire FGFR2 gene for pathogenic variants causing Saethre-Chotzen syndrome, a rare craniosynostosis disorder. With ISO-certified analysis and DHA-compliant clinical protocols, it delivers a definitive molecular diagnosis essential for personalized management and genetic counselling.
| Feature | Our ISO-Accredited Test | Closest Alternative |
|---|---|---|
| Precision | 99.9% sensitivity; full gene coverage + CNV analysis | Targeted Sanger sequencing – may miss large deletions |
| Methodology | Next-Generation Sequencing (NGS) – Illumina platform | Conventional Sanger or limited panel |
| Turnaround Time | 3 to 4 weeks | Often 6–8 weeks (multi-step) |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Genetics, I understand that awaiting a genetic diagnosis for your child can be deeply stressful. The FGFR2 NGS test provides a precise molecular answer, but it must be weighed together with craniofacial imaging and family history. Our team will guide you through every result, ensuring you have a clear care pathway before taking any treatment decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory & Caution
Do not discontinue prescribed medication without consulting your doctor. This genetic test does not replace ongoing clinical management; always follow your specialist’s advice.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Infants under 6 months without explicit medical necessity; severe coagulopathy; inability to provide informed consent from legal guardian.
- Emergency Signs: Symptoms of raised intracranial pressure (persistent projectile vomiting, sunsetting eyes, bulging fontanelle), new-onset seizures, respiratory difficulty, or sudden lethargy. Seek immediate emergency care if any of these appear.
Patient FAQ & Clinical Guidance
1. What is Saethre-Chotzen syndrome and why should I test the FGFR2 gene?
Saethre-Chotzen syndrome is a congenital disorder caused by mutations in the FGFR2 gene, leading to craniosynostosis and limb abnormalities. Early molecular diagnosis enables prophylactic surgical planning, targeted surveillance, and accurate genetic counselling for families, reducing long-term complications.
2. How is the sample collected for this DNA test?
The test requires a simple blood draw collected by a certified phlebotomist at home via our VIP mobile phlebotomy service. Our DHA-compliant cold-chain logistics ensure sample stability, and no special preparation is needed aside from a clinical history form and a genetic counselling session.
3. How long do results take and what support is provided?
Results are typically available within 3 to 4 weeks; you receive a teleconsultation to explain findings and next steps. Our multilingual team offers post-test clinical guidance and coordinates with your referring paediatrician or craniofacial surgeon, all in compliance with UAE PDPL data privacy laws.
UAE Regulatory & Data Privacy Adherence
This service adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. ISO 9001:2015 Certification: INT/EGQ/2509DA/3139.
Clinical & Logistical Metadata
| Test Name | FGFR2 Gene Saethre-Chotzen Syndrome Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 weeks (21–28 days) |
| Sample Type / Matrix | Peripheral whole blood |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina platform |
| ICD-10-CM Code | Q87.0 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | License 1143 |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians